Falls Church, VA (PRWEB) August 28, 2014
Subscribe to The GMP Letter
Steris Corporation was warned by the FDA for several violations related to employee data manipulation and falsification.
The company’s Libertyville, Ill., facility opened an investigation in July 2013 to look into instances where product was overdosed but later made to appear within specification.
However, the inspection fell short because it did not include a review of all potentially affected products, according to the May 22 warning letter posted recently online.
Steris also initiated local nonconformances for three instances of data manipulation at three separate facilities, but did not bump the issue to a corporate CAPA before the FDA’s inspection, the letter says. This would have allowed the company to address the issue across all STERIS Isomedix gamma irradiation facilities...
About The GMP Letter
For 30 years, devicemakers have relied on The GMP Letter for the latest on the FDA's interpretation and enforcement of cGMPs and Quality Systems Regulation, information readers need to stay in compliance.
Each monthly issue brings its readers updates on the FDA’s approach to facility inspections, changes to the EU’s unannounced inspections and the latest on joint inspections in these and other jurisdictions and brings the latest on:
- MDR reporting
Plus readers get links to Form 483s, warning letters, closeout letters, FDA policy notices and other reports to ensure that quality assurance efforts are a success.
Order NOW and pay just $835, a savings of $150 of the regular one-year price of $985.
4 EASY WAYS TO ORDER
By phone: 888-838-5578 or 703-538-7600
300 N Washington St
Falls Church VA USA 22046-3431
100% Money-Back Guarantee. FDAnews' ironclad guarantee ensures customer satisfaction. If at any time during the one-year subscription the customer becomes dissatisfied, they may cancel and receive a full refund. No questions asked.
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.